HOME|Our Favorites HEC Pharm


Home - Investor - Regulatory affairs
Regulatory affairs

Our regulatory affairs team includes more than 70 people. They have successfully completed dossier submission to the US and European countries. Several ANDAs and INDs (for NCE) have been approved by international regulatory authorities. One of our products Azithromycin tablet is listed on WHO prequalified medicine list, and more than 20DMFs and CEPs are available.

Copyright HEC Pharma Co., Ltd license key:粤ICP备19111996号